(Q39342575)

11 September 2017

A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy (English)

1 reference

11 September 2017

Huiping Wang

1

1 reference

11 September 2017

Fang Wei

2

1 reference

11 September 2017

Jufeng Zhang

3

1 reference

11 September 2017

Feng Wang

4

1 reference

11 September 2017

Huiming Li

5

1 reference

11 September 2017

Xiafang Chen

6

1 reference

11 September 2017

Kuangcheng Xie

7

1 reference

11 September 2017

Yufei Wang

8

1 reference

11 September 2017

Chuanyuan Li

9

1 reference

11 September 2017

Qian Huang

10

1 reference

11 September 2017

25 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

33

1 reference

11 September 2017

4

1 reference

11 September 2017

1245-1253

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-012-0374-7

11 September 2017

0 references

cites work

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Productive replication of human adenovirus type 5 in canine cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Oncolytic viruses in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Activity of recombinant human interleukin-15 against tumor recurrence and metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Shedding light on immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Current strategies and future directions for eluding adenoviral vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

Productive replication of human adenoviruses in mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0374-7

50 years of preclinical anticancer drug screening: empirical to target-driven approaches.

21 January 2018

1 reference

12 December 2020

Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies

1 reference

12 December 2020

Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.

1 reference

12 December 2020

Distribution, persistency, toxicity, and lack of replication of an E1A-deficient adenoviral vector after intracardiac delivery in the cotton rat

1 reference

12 December 2020

Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes

1 reference

12 December 2020

Basic concept of development and practical application of animal models for human diseases.

1 reference

12 December 2020

Circumvention of immunity to the adenovirus major coat protein hexon.

1 reference

12 December 2020

Microsatellite genotyping for four expected inbred mouse strains from KM mice

1 reference

12 December 2020

10.1007/S13277-012-0374-7

Identifiers

DOI

1 reference

11 September 2017

1 reference